Trident Texofab standalone net profit rises 90.00% in the December 2025 quarter
Sales decline 18.78% to Rs 25.74 crore
Net profit of Trident Texofab rose 90.00% to Rs 0.57 crore in the quarter ended December 2025 as against Rs 0.30 crore during the previous quarter ended December 2024. Sales declined 18.78% to Rs 25.74 crore in the quarter ended December 2025 as against Rs 31.69 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales25.7431.69 -19 OPM %6.377.29 -PBDT1.250.68 84 PBT0.840.27 211 NP0.570.30 90Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 13 2026 | 9:18 AM IST